[HTML][HTML] COVID-19 and the kidney: from epidemiology to clinical practice
I Gagliardi, G Patella, A Michael, R Serra… - Journal of clinical …, 2020 - mdpi.com
The new respiratory infectious disease coronavirus disease 2019 (COVID-19) that
originated in Wuhan, China, in December 2019 and caused by a new strain of zoonotic …
originated in Wuhan, China, in December 2019 and caused by a new strain of zoonotic …
[HTML][HTML] Guidance for the management of patients with vascular disease or cardiovascular risk factors and COVID-19: position paper from VAS-European independent …
GT Gerotziafas, M Catalano, MP Colgan… - Thrombosis and …, 2020 - thieme-connect.com
COVID-19 is also manifested with hypercoagulability, pulmonary intravascular coagulation,
microangiopathy, and venous thromboembolism (VTE) or arterial thrombosis. Predisposing …
microangiopathy, and venous thromboembolism (VTE) or arterial thrombosis. Predisposing …
The use of renin angiotensin system inhibitor on mortality in patients with coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis
Abstract Background and Aims; To investigate the association between use of angiotensin-
converting enzyme inhibitor (ACEI)/angiotensin-receptor blocker (ARB) and outcomes of …
converting enzyme inhibitor (ACEI)/angiotensin-receptor blocker (ARB) and outcomes of …
[HTML][HTML] COVID-19 and cardiovascular diseases
F Mai, R Del Pinto, C Ferri - Journal of cardiology, 2020 - Elsevier
Abstract Infection by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
is responsible for the second pandemic of the XXI century after influenza A in 2009. As of …
is responsible for the second pandemic of the XXI century after influenza A in 2009. As of …
[HTML][HTML] Association between COVID-19 prognosis and disease presentation, comorbidities and chronic treatment of hospitalized patients
A Rodríguez-Molinero, C Gálvez-Barrón, A Miñarro… - PloS one, 2020 - journals.plos.org
Importance The rapid pandemic expansion of the disease caused by the new SARS-CoV-2
virus has compromised health systems worldwide. Knowledge of prognostic factors in …
virus has compromised health systems worldwide. Knowledge of prognostic factors in …
Effects of angiotensin receptor blockers (ARBs) on in-hospital outcomes of patients with hypertension and confirmed or clinically suspected COVID-19
A Soleimani, S Kazemian… - American Journal of …, 2020 - academic.oup.com
BACKGROUND There is an ongoing controversy about harms and benefits of angiotensin-
converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs) in …
converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs) in …
[HTML][HTML] Mortality and disease severity among COVID-19 patients receiving renin-angiotensin system inhibitors: a systematic review and meta-analysis
Introduction The use of renin-angiotensin system (RAS) inhibitors, including angiotensin-
converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs), was …
converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs), was …
Influence of blood pressure control and application of renin‐angiotensin‐aldosterone system inhibitors on the outcomes in COVID‐19 patients with hypertension
R Chen, J Yang, X Gao, X Ding, Y Yang… - The Journal of …, 2020 - Wiley Online Library
Hypertension is proved to be associated with severity and mortality in coronavirus disease
2019 (COVID‐19). However, little is known about the effects of pre‐admission and/or in …
2019 (COVID‐19). However, little is known about the effects of pre‐admission and/or in …
Angiotensin converting enzyme inhibitors and angiotensin II receptor blockers and outcomes in patients with COVID-19: a systematic review and meta-analysis
Background The use of angiotensin-converting enzyme inhibitors (ACEI) and angiotensin II
receptor blockers (ARB) in patients with coronavirus disease 2019 (COVID-19) given their …
receptor blockers (ARB) in patients with coronavirus disease 2019 (COVID-19) given their …
[HTML][HTML] Angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers and the risk of COVID-19 infection or severe disease: systematic review and …
Objective Animal studies suggested that angiotensin-converting enzyme inhibitors (ACEi)
and angiotensin-receptor blockers (ARB) facilitate the inoculation of potentially leading to a …
and angiotensin-receptor blockers (ARB) facilitate the inoculation of potentially leading to a …